USANA Health Sciences, Inc.
USNA
$14.96
$0.533.67%
NYSE
| 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 913.36M | 925.94M | 925.26M | 912.67M | 899.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 913.36M | 925.94M | 925.26M | 912.67M | 899.22M |
| Cost of Revenue | 206.00M | 207.84M | 200.85M | 190.00M | 180.44M |
| Gross Profit | 707.36M | 718.09M | 724.41M | 722.67M | 718.78M |
| SG&A Expenses | 665.88M | 669.03M | 673.54M | 672.61M | 654.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 871.87M | 876.87M | 874.40M | 862.60M | 834.78M |
| Operating Income | 41.49M | 49.07M | 50.86M | 50.07M | 64.44M |
| Income Before Tax | 2.54M | 40.25M | 41.53M | 47.78M | 64.59M |
| Income Tax Expenses | 31.79M | 31.11M | 30.05M | 30.22M | 29.77M |
| Earnings from Continuing Operations | -29.25 | 9.15 | 11.48 | 17.56 | 34.83 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 7.09M | -273.00K | -717.00K | -567.00K | -707.00K |
| Net Income | -22.16M | 8.87M | 10.76M | 16.99M | 34.12M |
| EBIT | 41.49M | 49.07M | 50.86M | 50.07M | 64.44M |
| EBITDA | 73.92M | 81.57M | 83.42M | 78.07M | 88.09M |
| EPS Basic | -1.20 | 0.48 | 0.56 | 0.89 | 1.80 |
| Normalized Basic EPS | 1.92 | 1.81 | 1.81 | 1.83 | 2.37 |
| EPS Diluted | -1.21 | 0.47 | 0.55 | 0.88 | 1.79 |
| Normalized Diluted EPS | 1.92 | 1.81 | 1.81 | 1.82 | 2.36 |
| Average Basic Shares Outstanding | 73.48M | 73.51M | 74.16M | 74.96M | 75.74M |
| Average Diluted Shares Outstanding | 73.49M | 73.54M | 74.22M | 75.02M | 75.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |